1. The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades
   Yan Wu et al, 2018, Therapeutic Advances in Medical Oncology CrossRef
2. Therapeutic opportunities in colon cancer: Focus on phosphodiesterase inhibitors
   Ankita Mehta et al, 2019, Life Sciences CrossRef
3. STAT1 Inhibits MiR‐181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN/Akt
   Xingwen Zhang et al, 2017, Journal of Cellular Biochemistry CrossRef
4. Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats
   Yongying Hou et al, 2018, Genes & Diseases CrossRef
5. Genistein Directly Represses the Phosphorylation of STAT5 in Lactating Mammary Epithelial Cells
   Yusaku Tsugami et al, 2021, ACS Omega CrossRef
6. Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers
   Akram Mohammed et al, 2017, Oncotarget CrossRef
7. Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways
   Yan Wu et al, 2019, Bioscience Reports CrossRef